Magnetoencephalography Market Size, Share & Trends Analysis Report By Technology (Superconducting Magnetoencephalography (sMEG), Optically Pumped Magnetometers (OPM)), By Applications (Clinical, Dementia, Autism, Schizophrenia, Multiple Sclerosis, Stroke, Epilepsy, Others, Research), By End-User (Hospitals and Clinics, Research Institutes, Academic Institutions) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Jay Mehta | Format:

Market Segmentation

  1. Magnetoencephalography Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Superconducting Magnetoencephalography (sMEG)
    2. Optically Pumped Magnetometers (OPM)
  2. Magnetoencephalography Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Clinical
    2. Dementia
    3. Autism
    4. Schizophrenia
    5. Multiple Sclerosis
    6. Stroke
    7. Epilepsy
    8. Others
    9. Research
  3. Magnetoencephalography Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Research Institutes
    3. Academic Institutions
  4. Regional Magnetoencephalography Market
    1. North America
      1. North America Magnetoencephalography Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
      2. North America Magnetoencephalography Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Clinical
        2. Dementia
        3. Autism
        4. Schizophrenia
        5. Multiple Sclerosis
        6. Stroke
        7. Epilepsy
        8. Others
        9. Research
      3. North America Magnetoencephalography Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Institutes
        3. Academic Institutions
      4. U.S.
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      5. Canada
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
    2. Europe
      1. Europe Magnetoencephalography Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
      2. Europe Magnetoencephalography Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Clinical
        2. Dementia
        3. Autism
        4. Schizophrenia
        5. Multiple Sclerosis
        6. Stroke
        7. Epilepsy
        8. Others
        9. Research
      3. Europe Magnetoencephalography Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Institutes
        3. Academic Institutions
      4. U.K.
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      5. Germany
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      6. France
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      7. Spain
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      8. Italy
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      9. Russia
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      10. Nordic
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      11. Benelux
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      12. Rest of Europe
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
    3. APAC
      1. APAC Magnetoencephalography Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
      2. APAC Magnetoencephalography Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Clinical
        2. Dementia
        3. Autism
        4. Schizophrenia
        5. Multiple Sclerosis
        6. Stroke
        7. Epilepsy
        8. Others
        9. Research
      3. APAC Magnetoencephalography Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Institutes
        3. Academic Institutions
      4. China
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      5. Korea
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      6. Japan
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      7. India
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      8. Australia
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      9. Taiwan
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      10. South East Asia
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      11. Rest of Asia-Pacific
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
    4. Middle East and Africa
      1. Middle East and Africa Magnetoencephalography Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
      2. Middle East and Africa Magnetoencephalography Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Clinical
        2. Dementia
        3. Autism
        4. Schizophrenia
        5. Multiple Sclerosis
        6. Stroke
        7. Epilepsy
        8. Others
        9. Research
      3. Middle East and Africa Magnetoencephalography Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Institutes
        3. Academic Institutions
      4. UAE
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      5. Turkey
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      6. Saudi Arabia
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      7. South Africa
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      8. Egypt
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      9. Nigeria
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      10. Rest of MEA
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
    5. LATAM
      1. LATAM Magnetoencephalography Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
      2. LATAM Magnetoencephalography Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Clinical
        2. Dementia
        3. Autism
        4. Schizophrenia
        5. Multiple Sclerosis
        6. Stroke
        7. Epilepsy
        8. Others
        9. Research
      3. LATAM Magnetoencephalography Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Institutes
        3. Academic Institutions
      4. Brazil
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      5. Mexico
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      6. Argentina
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      7. Chile
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      8. Colombia
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions
      9. Rest of LATAM
        1. Superconducting Magnetoencephalography (sMEG)
        2. Optically Pumped Magnetometers (OPM)
        3. Clinical
        4. Dementia
        5. Autism
        6. Schizophrenia
        7. Multiple Sclerosis
        8. Stroke
        9. Epilepsy
        10. Others
        11. Research
        12. Hospitals and Clinics
        13. Research Institutes
        14. Academic Institutions

We are featured on: